Related references
Note: Only part of the references are listed.Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier
Major Gooyit et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood-Brain Barrier Damage in Early Ischemic Stroke Stage
Jie Liu et al.
JOURNAL OF NEUROSCIENCE (2012)
Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia
Jiankun Cui et al.
MOLECULAR NEURODEGENERATION (2012)
Critical Role of NADPH Oxidase in Neuronal Oxidative Damage and Microglia Activation following Traumatic Brain Injury
Quan-Guang Zhang et al.
PLOS ONE (2012)
Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease
J. M. Walker et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Matrix metalloproteinase-9 controls proliferation of NG2+progenitor cells immediately after spinal cord injury
Huaqing Liu et al.
EXPERIMENTAL NEUROLOGY (2011)
Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia
Wenwen Sheng et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke
Jeffrey A. Switzer et al.
STROKE (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury
Kenji Dohi et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization
Carson K. Lam et al.
NATURE (2010)
Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging
Robert D. Bell et al.
NEURON (2010)
Matrix Metalloproteinases and Neurotrauma: Evolving Roles in Injury and Reparative Processes
Haoqian Zhang et al.
NEUROSCIENTIST (2010)
Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies
David J. Loane et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Active Site Ring-Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases
Christopher Forbes et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
A Potent Gelatinase Inhibitor with Anti-Tumor-Invasive Activity and its Metabolic Disposition
Mijoon Lee et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Gary A. Rosenberg
LANCET NEUROLOGY (2009)
Traumatic Brain Injury in the United States: An Epidemiologic Overview
Carl R. Summers et al.
MOUNT SINAI JOURNAL OF MEDICINE (2009)
ELEVATION OF MATRIX METALLOPROTEINASES 3 AND 9 IN CEREBROSPINAL FLUID AND BLOOD IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY
Mark Grossetete et al.
NEUROSURGERY (2009)
A relationship between slide quality and image quality in whole slide imaging (WSI)
Yukako Yagi et al.
DIAGNOSTIC PATHOLOGY (2008)
Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury
Fengshan Yu et al.
JOURNAL OF NEUROTRAUMA (2008)
Metabolism of a highly selective gelatinase inhibitor generates active metabolite
Mijoon Lee et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
Armin Buss et al.
BMC NEUROLOGY (2007)
Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury
David L. Brody et al.
JOURNAL OF NEUROTRAUMA (2007)
Microglial activation and matrix protease generation during focal cerebral ischemia
Gregory J. del Zoppo et al.
STROKE (2007)
Blood-brain barrier delivery
William M. Pardridge
DRUG DISCOVERY TODAY (2007)
Role of matrix metalloproteinases in delayed cortical responses after stroke
BQ Zhao et al.
NATURE MEDICINE (2006)
Metalloproteinases: Mediators of pathology and regeneration in the CNS
VW Yong
NATURE REVIEWS NEUROSCIENCE (2005)
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia
ZZ Gu et al.
JOURNAL OF NEUROSCIENCE (2005)
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
ML Block et al.
PROGRESS IN NEUROBIOLOGY (2005)
Brain-specific knock-out of hypoxia-inducible factor-1α reduces rather than increases hypoxic-ischemic damage
R Helton et al.
JOURNAL OF NEUROSCIENCE (2005)
Regulation of matrix biology by matrix metalloproteinases
JD Mott et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients - Influence of different therapies
S Horstmann et al.
STROKE (2003)
S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death
ZZ Gu et al.
SCIENCE (2002)
Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke
J Montaner et al.
STROKE (2001)
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2
M Toth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Potent and selective mechanism-based inhibition of gelatinases
S Brown et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Share Paper
